DK1140925T3 - 3,4-Dihydro-2H-benzo[1,4]oxazinyl-methyl)-[3-(1H-indol-3-yl)-alkylaminer]-aminer - Google Patents

3,4-Dihydro-2H-benzo[1,4]oxazinyl-methyl)-[3-(1H-indol-3-yl)-alkylaminer]-aminer

Info

Publication number
DK1140925T3
DK1140925T3 DK00902331T DK00902331T DK1140925T3 DK 1140925 T3 DK1140925 T3 DK 1140925T3 DK 00902331 T DK00902331 T DK 00902331T DK 00902331 T DK00902331 T DK 00902331T DK 1140925 T3 DK1140925 T3 DK 1140925T3
Authority
DK
Denmark
Prior art keywords
oxazinyl
alkylamines
indol
benzo
dihydro
Prior art date
Application number
DK00902331T
Other languages
English (en)
Inventor
Richard Eric Mewshaw
Dahui Zhou
Ping Zhou
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1140925T3 publication Critical patent/DK1140925T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Indole Compounds (AREA)
DK00902331T 1999-01-07 2000-01-06 3,4-Dihydro-2H-benzo[1,4]oxazinyl-methyl)-[3-(1H-indol-3-yl)-alkylaminer]-aminer DK1140925T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22683199A 1999-01-07 1999-01-07
PCT/US2000/000230 WO2000040580A1 (en) 1999-01-07 2000-01-06 3,4-dihydro-2h-benzo[1,4]oxazinyl-methyl[3-(1h-indol-3-yl)-alkyl]-amines

Publications (1)

Publication Number Publication Date
DK1140925T3 true DK1140925T3 (da) 2003-08-11

Family

ID=22850596

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00902331T DK1140925T3 (da) 1999-01-07 2000-01-06 3,4-Dihydro-2H-benzo[1,4]oxazinyl-methyl)-[3-(1H-indol-3-yl)-alkylaminer]-aminer

Country Status (12)

Country Link
EP (1) EP1140925B1 (da)
JP (1) JP2002534427A (da)
CN (1) CN1335845A (da)
AT (1) ATE238300T1 (da)
AU (1) AU2406700A (da)
CA (1) CA2355308A1 (da)
DE (1) DE60002292T2 (da)
DK (1) DK1140925T3 (da)
ES (1) ES2193047T3 (da)
PT (1) PT1140925E (da)
TW (1) TW546299B (da)
WO (1) WO2000040580A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE357448T1 (de) 2000-10-26 2007-04-15 Smithkline Beecham Plc Benzoxazinonderivative, deren herstellung und verwendung
EP1373203A1 (en) 2001-03-29 2004-01-02 Bristol-Myers Squibb Company Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
WO2004106298A1 (en) * 2003-05-30 2004-12-09 Janssen Pharmaceutica N.V. Indole derivatives with an improved antipsychotic activity
EP2314585B1 (en) 2004-07-15 2012-09-12 Japan Tobacco, Inc. Condensed benzamide compounds as inhibitors of vanilloid receptor subtype 1 (VR1) activity
CA2585857A1 (en) 2004-11-26 2006-06-01 Janssen Pharmaceutica N.V. Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity
US7906508B2 (en) 2005-12-28 2011-03-15 Japan Tobacco Inc. 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8803419D0 (en) * 1988-02-15 1988-03-16 Erba Carlo Spa 1 4-benzoxazine & 1 4-benzothiazine derivatives & process for their preparation
JP2002510682A (ja) * 1998-04-08 2002-04-09 アメリカン・ホーム・プロダクツ・コーポレイション うつ病治療用のインドール−3−イル−シクロヘキシルアミン誘導体(5−ht1受容体拮抗薬)

Also Published As

Publication number Publication date
CN1335845A (zh) 2002-02-13
EP1140925B1 (en) 2003-04-23
PT1140925E (pt) 2003-08-29
EP1140925A1 (en) 2001-10-10
ATE238300T1 (de) 2003-05-15
WO2000040580A1 (en) 2000-07-13
ES2193047T3 (es) 2003-11-01
JP2002534427A (ja) 2002-10-15
CA2355308A1 (en) 2000-07-13
DE60002292D1 (de) 2003-05-28
DE60002292T2 (de) 2003-10-23
TW546299B (en) 2003-08-11
AU2406700A (en) 2000-07-24

Similar Documents

Publication Publication Date Title
NZ514873A (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
PT1159279E (pt) 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais
PT870768E (pt) Derivados azaindole-etilamina como agentes de ligacao nicotinicos aos receptores de acetilcolina
ATE266013T1 (de) 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4)
ZA959444B (en) Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation.
EP1642880A4 (en) PROTEIN INHIBITOR OF THE HSP90 FAMILY
AU6947401A (en) Phenylpyridazine derivatives and drugs containing the same
PT918776E (pt) Sintese total de acilfulvenos antitumorais
PE34996A1 (es) Nuevo derivado de pirrocarbazol
ATE272617T1 (de) Sulfonamid-derivate
EP1142881A4 (en) POLY (ADP-RIBOSE) POLYMERASE INHIBITORS CONSISTING OF PYRIMIDINE DERIVATIVES
MY131096A (en) N-imidazolyl derivatives of substituted indole.
DK1140925T3 (da) 3,4-Dihydro-2H-benzo[1,4]oxazinyl-methyl)-[3-(1H-indol-3-yl)-alkylaminer]-aminer
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
WO2002094770A3 (en) Aminoalcohol derivatives
HRP20000027B1 (en) Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds
AP2002002595A0 (en) Heterocyclic amide derivatives.
SE8901060D0 (sv) New compounds
MXPA04000615A (es) Compuestos utiles para el tratamiento o la prevencion de enfermedades mediadas por alfa-2b-adrenoceptor.
RS50449B (sr) Supstituisani bisindolilmaleimidi za inhibiciju proliferacije ćelija
ES2182775T3 (es) Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion.
CA2245896A1 (en) A therapeutic agent for renal disease
CY1110529T1 (el) Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων